Prognostic value of immunohistochemically identified CEA, SC, AFP, and S-100 protein-positive cells in gastric carcinoma.
Gastric tissues from 85 patients with advanced carcinoma were studied immunohistochemically for localization of carcinoembryonic antigen (CEA), secretory component (SC) and alpha-fetoprotein (AFP), and for S-100 protein-positive cells. Our objective was to determine if these factors could serve as prognostic indicators. Forty patients died of recurrence or metastases within 2 years (Group I), and the remaining 45 survived 10 years or longer (Group II) after resection. CEA-positive cells were present in 93% and 89% of Groups I and II, respectively. In case of staining for CEA, positive results were seen not only in the malignant cells but also in the stroma in 35% of Group I but none in Group II. The immunohistochemical status of SC was not essentially different between Groups I and II; the positive staining was recognized in 50% and in 57%, respectively. Gastric carcinomas rarely reacted to AFP. S-100 protein-positive cells, which play an important role in local immunity, were often present in Group II (47%) but rarely in Group I (10%). Thus, in addition to the various prognostic factors available to the surgical pathologist, the presence of CEA and the appearance of S-100 protein-positive cells in tumor tissue will aid in predicting the prognosis of patients with advanced gastric carcinoma.
Mori
M
M
Second Department of Pathology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Ambe
K
K
Adachi
Y
Y
Yakeishi
Y
Y
Nakamura
K
K
Hachitanda
Y
Y
Enjoji
M
M
Sugimachi
K
K
D014408:Biomarkers, Tumor / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D006801:Humans; D007124:Immunoenzyme Techniques; D007128:Immunoglobulin Fragments / Q000032:analysis*; D007150:Immunohistochemistry; D009362:Neoplasm Metastasis; D011379:Prognosis; D009418:S100 Proteins / Q000032:analysis*; D012635:Secretory Component / Q000032:analysis*; D013274:Stomach Neoplasms / Q000473:pathology*; D000509:alpha-Fetoproteins / Q000032:analysis*
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D007128:Immunoglobulin Fragments; D009418:S100 Proteins; D012635:Secretory Component; D000509:alpha-Fetoproteins